Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Vaccines
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy term 2-month-old infants for whom a parent/legal representative has given written informed consent.
You may not be if
Subjects with a previous or suspected disease caused by Neisseria meningitidis, Corynebacterium diphtheriae, Clostridium tetani, Poliovirus, Hepatitis B, Haemophilus influenzae type b (Hib), Pneumococcus or Bordetella pertussis; previous immunization with a meningococcal vaccine or vaccine containing meningococcal antigen(s) or prior vaccination with Diptheria, Tetanus, Pertussis (acellular or whole cell), inactivated polio vaccineIPV or oral polio vaccineOPV, H. influenzae type b (Hib) or Pneumococcus; who have had household contact with and/or intimate exposure to an individual with laboratory confirmed N. meningitidis (serogroups A, C, W-135, or Y), B. pertussis, Hib, C. diphtheriae, Polio, or pneumococcal infection at any time since birth; Any serious acute, chronic or progressive disease
Clareo Health | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
